Similar to KRAS mutations, several analyses of circulating EVs from NSCLC patients showedthe presence of clinically relevant epidermal growth factor receptor (EGFR)-specificmutations[145,146]. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.